AAL

Moderna Stock Soars on Vaccine Funding

The equity is up 45.8% in the last week

Deputy Editor
Apr 17, 2020 at 1:11 PM
facebook X logo linkedin


Gilead Sciences (GILD) isn't the only one making headlines today in regards to COVID-19. Shares of Moderna Inc (NASDAQ:MRNA) are soaring, after the company received a $483 million from the Biomedical Advanced Research and Development Authority (BARDA) to accelerate the development of its coronavirus vaccine. Following the news, Piper Sandler raised its price target to $57 from $34. At last check, Moderna is up 14.4% to trade at $46.46, earlier hitting a fresh record high of $49.

MRNA stock has  been on the rise following a slew of vaccine news and announcements since the start of the pandemic.  Support from its 20-day moving average has also contributed to today's impressive bull gap, leading the way to the equity's now 138% year-to-date gain.

mrna chart april 17

Analysts are bullish coming into today, with seven out of eight analysts in coverage sporting a "strong buy" or "buy" rating, with the remaining considering a "hold." Furthermore, Moderna stock has long-since surpassed its 12-month consensus target price of $39.89.

Digging deeper, short interest has surged 17.4% in the last two reporting periods, and now makes up 23.66 million shares. This accounts for 11.9% of the stock's available float, and would take almost two days for shorts to buy back their bearish bets, at the stock's average pace of trading. 


 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.